• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 9
  • 4
  • Tagged with
  • 9
  • 9
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

The single cell suspension culture of the licorice plant, Glycyrrhiza glabra

Wu, Chiu Hui January 1970 (has links)
The cells of the licorice plant, Glycyrrhiza glabra, were cultured as a "single cell" suspension. Their growth behaviour, yield and metabolic products were studied. The suspension cultures of the licorice plant were established from the friable calluses obtained from the radicle, cotyledon and hypocotyl of the germinated seeds. The single cells, regardless of their origin showed little difference in cell size and morphology. After an apparent adjustment to the medium, the cells required 11-13 days of incubation to reach the maximum cell yield of 1.2 gm/100 ml medium, dry weight. During the growth period, the pH of the growth medium decreased from pH 5.6 to pH 4.7 in the first few days and then increased to about pH 6. A level of 10% coconut milk in PRL-4-CM medium was found to support good cell growth; the lower the coconut milk level, the longer the growth period required to reach the maximum cell yield. It was also found that 0.57% yeast extract could be used to replace the coconut milk in the PRL-4-CCM medium. The metabolites detected and examined in the licorice single cell suspension culture included a volatile apple aroma, a polysaccharide pectin-like material, steroids and triterpenoids. The analyses of the licorice cell volatile apple aroma found under anaerobic conditions indicated the presence of ethanol and some related esters. The monosaccharides found in the pectin-like polysaccharide hydrolysate were glucose, fructose, galactose, arabinose, xylose, galacturonic acid and glucuronic acid. The pectin-like material in the cell preparations reached a maximum yield of 1.1 mg/ml after one month of growth. Glycyrrhizinic acid, the common licorice constituent found in the root, could not be detected in the suspension cultures. However, several other related compounds which gave typical steroid and triterpenoid reactions were found. Sorbitol and fructose were found to be the two major sugars which accumulated in free form in the licorice cell medium. / Land and Food Systems, Faculty of / Graduate
2

Anti-proliferative and differentiation-inducing effects of glycyrrhizin and 18[beta]-glycyrrhetinic acid on neuroblastoma cells in vitro.

January 2003 (has links)
Lee Kin-wah. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2003. / Includes bibliographical references (leaves 187-203). / Abstracts in English and Chinese. / ACKNOWLEDGEMENTS --- p.i / ABBREVIATIONS --- p.ii / ABSTRACT --- p.vi / CHINESE ABSTRACT --- p.ix / TABLE OF CONTENTS --- p.xii / Chapter CHAPTER 1: --- GENERAL INTRODUCTION --- p.1 / Chapter 1.1 --- Neuroblastoma-An Overview --- p.1 / Chapter 1.1.1 --- Epidemiology of Neuroblastoma --- p.1 / Chapter 1.1.2 --- Clinical Presentations of Neuroblastoma --- p.2 / Chapter 1.1.3 --- Diagnosis of Neuroblastoma --- p.3 / Chapter 1.1.4 --- Staging of Neuroblastoma --- p.5 / Chapter 1.1.5 --- Prognostic Considerations of Neuroblastoma --- p.6 / Chapter 1.1.5.1 --- Age --- p.6 / Chapter 1.1.5.2 --- Primary Tumor Site --- p.6 / Chapter 1.1.5.3 --- Tumor Histopathology --- p.7 / Chapter 1.1.5.4 --- Serum Markers --- p.9 / Chapter 1.1.5.5 --- Genetic Markers --- p.9 / Chapter 1.1.6 --- Standard Treatment Modalities for Neuroblastoma --- p.11 / Chapter 1.1.6.1 --- Surgery --- p.11 / Chapter 1.1.6.2 --- Chemotherapy --- p.12 / Chapter 1.1.6.3 --- Radiotherapy --- p.13 / Chapter 1.1.7 --- Differentiation of Neuroblastoma In Vivo and In Vitro --- p.14 / Chapter 1.1.8 --- Differentiation Therapy of Neuroblastoma --- p.16 / Chapter 1.2 --- Glycyrrhizin ´ؤ the Major Active Component of Licorice --- p.17 / Chapter 1.2.1 --- Chemistry of Licorice --- p.17 / Chapter 1.2.2 --- Metabolism of Glycyrrhizin --- p.21 / Chapter 1.2.3 --- Pharmacological Effects of Glycyrrhizin and 18β-Glycyrrhetinic Acid --- p.22 / Chapter 1.2.3.1 --- Anti-inflammatory Effect --- p.22 / Chapter 1.2.3.2 --- Hepatoprotective Effect --- p.23 / Chapter 1.2.3.3 --- Anti-carcinogenic and Anti-tumor Effects --- p.25 / Chapter 1.2.3.4 --- Anti-viral Effect --- p.27 / Chapter 1.2.3.5 --- Immunomodulatory Effect --- p.29 / Chapter 1.2.3.6 --- Mineralocorticoid Effect --- p.30 / Chapter 1.2.4 --- Pharmacokinetics of Glycyrrhizin and Glycyrrhetinic Acid --- p.32 / Chapter 1.2.5 --- Health Hazards of Glycyrrhizin and Glycyrrhetinic Acid --- p.33 / Chapter 1.3 --- Aims and Scopes of This Study --- p.36 / Chapter CHAPTER 2: --- MATERIALS AND METHODS --- p.39 / Chapter 2.1 --- Materials --- p.39 / Chapter 2.1.1 --- Cell Lines --- p.39 / Chapter 2.1.2 --- "Cell Culture Media, Buffers and Other Reagents" --- p.39 / Chapter 2.1.3 --- Drugs and Chemicals --- p.43 / Chapter 2.1.4 --- Reagents for 3H-Thymidine Incorporation Assay --- p.44 / Chapter 2.1.5 --- Reagents for Neutral Red Assay --- p.45 / Chapter 2.1.6 --- Reagents for Clonogenic Assay --- p.45 / Chapter 2.1.7 --- Reagents and Buffers for Immunocytochemistry --- p.46 / Chapter 2.1.8 --- Reagents for DNA Extraction --- p.48 / Chapter 2.1.9 --- Reagent for DNA Staining --- p.49 / Chapter 2.1.10 --- Reagents and Buffers for Flow Cytometry --- p.49 / Chapter 2.1.11 --- Reagents for Total RNA Isolation --- p.50 / Chapter 2.1.12 --- Reagents and Buffers for RT-PCR --- p.50 / Chapter 2.1.13 --- Reagents and Buffers for Gel Electrophoresis --- p.55 / Chapter 2.1.14 --- Reagents and Buffers for Western Blot Analysis --- p.56 / Chapter 2.2 --- Methods --- p.62 / Chapter 2.2.1 --- Cell Culture Methodology --- p.62 / Chapter 2.2.2 --- Determination of Cell Proliferation --- p.62 / Chapter 2.2.3 --- Determination of Cell Viability by Trypan Blue Exclusion Test --- p.64 / Chapter 2.2.4 --- Limiting Dilution Assay --- p.65 / Chapter 2.2.5 --- Clonogenic Assay --- p.65 / Chapter 2.2.6 --- Measurement of Apoptosis by DNA Fragmentation Analysis --- p.66 / Chapter 2.2.7 --- Assessment of Apoptosis by Hoechst 33342 Staining --- p.67 / Chapter 2.2.8 --- Cell Morphological Study --- p.67 / Chapter 2.2.9 --- Immunocytochemistry --- p.68 / Chapter 2.2.10 --- Flow Cytometric Analysis of Cell Cycle Profile --- p.69 / Chapter 2.2.11 --- Gene Expression Study --- p.70 / Chapter 2.2.12 --- Protein Expression Study --- p.73 / Chapter 2.2.13 --- Statistical Analysis --- p.76 / Chapter CHAPTER 3: --- ANTI-PROLIFERATIVE EFFECTS OF GLYCYRRHIZIN AND 18β-GLYCYRRHETINIC ACID ON NEUROBLASTOMA CELLS --- p.77 / Chapter 3.1 --- Introduction --- p.77 / Chapter 3.2 --- Results --- p.79 / Chapter 3.2.1 --- Differential Anti-proliferative Effect of Glycyrrhizin and 18β- Glycyrrhetinic Acid on Various Neuroblastoma Cell Lines In Vitro --- p.79 / Chapter 3.2.2 --- Effect of 18P-Glycyrrhetinic Acid on the Clonogenicity of the Murine Neuroblastoma BU-1 Cells In Vitro --- p.91 / Chapter 3.2.3 --- Kinetic and Reversibility Studies of the Anti-proliferative Effect of Glycyrrhizin and 18β-Glycyrrhetinic Acid on the Neuroblastoma BU-1 Cells --- p.93 / Chapter 3.2.4 --- Cytotoxic Effect of Glycyrrhizin and 18β-Glycyrrhetinic Acid on the Neuroblastoma BU-1 Cells In Vitro --- p.100 / Chapter 3.2.5 --- Inability of Glycyrrhizin and 18β-Glycyrrhetinic Acid to Induce DNA Fragmentation in the Neuroblastoma BU-1 Cells --- p.102 / Chapter 3.3 --- Discussion --- p.107 / Chapter CHAPTER 4: --- DIFFERENTIATION-INDUCING EFFECTS OF GLYCYRRHIZIN AND 18β-GLYCYRRHETINIC ACID ON NEUROBLASTOMA CELLS --- p.112 / Chapter 4.1 --- Introduction --- p.112 / Chapter 4.2 --- Results --- p.114 / Chapter 4.2.1 --- Morphological Changes in Glycyrrhizin and 18β-Glycyrrhetinic Acid-treated Neuroblastoma BU-1 Cells --- p.114 / Chapter 4.2.2 --- Immunocytochemistry of Glycyrrhizin and 18β-Glycyrrhetinic Acid-treated Neuroblastoma BU-1 Cells --- p.118 / Chapter 4.2.3 --- Effect of 18β-Glycyrrhetinic Acid on the Expression of Proto-oncogenes in Neuroblastoma BU-1 Cells --- p.124 / Chapter 4.2.4 --- Effect of 18β-Glycyrrhetinic Acid on the Expression of Differentiation-Related Genes in Neuroblastoma BU-1 Cells --- p.127 / Chapter 4.3 --- Discussion --- p.130 / Chapter CHAPTER 5: --- MECHANISTIC STUDIES ON THE ANTI-PROLIFERATIVE AND DIFFERENTIATION-INDUCING EFFECTS OF GLYCYRRHIZIN AND 18β-GLYCYRRHETINIC ACID --- p.136 / Chapter 5.1 --- Introduction --- p.136 / Chapter 5.2 --- Results --- p.139 / Chapter 5.2.1 --- Effects of Glycyrrhizin and 18β-Glycyrrhetinic Acid on the Cell Cycle Kinetics of Neuroblastoma BU-1 Cells In Vitro --- p.139 / Chapter 5.2.2 --- Modulatory Effects of 18β-Glycyrrhetinic Acid on the Expression of Cell Cycle Regulatory Genes and Proteins --- p.145 / Chapter 5.2.3 --- "Combined Effects of Glycyrrhizin, 18β-Glycyrrhetinic Acid and All-Trans Retinoic Acid on the Proliferation of Neuroblastoma BU-1 Cells In Vitro" --- p.149 / Chapter 5.2.4 --- "Combined Effects of Glycyrrhizin, 18β-Glycyrrhetinic Acid and All-Trans Retinoic Acid on the Differentiation of Neuroblastoma BU-1 Cells In Vitro" --- p.153 / Chapter 5.2.5 --- Modulatory Effect of 18β-Glycyrrhetinic Acid on the Expression of PKC Isoforms in Neuroblastoma BU-1 Cells --- p.156 / Chapter 5.2.6 --- The Possible Involvement of Protein Kinase C in the Anti-proliferative and Differentiation-Inducing Effects of 18β-Glycyrrhetinic Acid on the Neuroblastoma BU-1 Cells --- p.158 / Chapter 5.2.7 --- The Possible Involvement of Protein Kinase A in the Anti-proliferative and Differentiation-Inducing Effects of 18β-Glycyrrhetinic Acid on the Neuroblastoma BU-1 Cells --- p.165 / Chapter 5.3 --- Discussion --- p.173 / Chapter CHAPTER 6: --- CONCLUSIONS AND FUTURE PERSPECTIVES --- p.182 / REFERENCES --- p.187
3

Expression of UDP-glucuronosyltransferases (UGTs) in rat liver cells induced by an aqueous extract of licorice root. / CUHK electronic theses & dissertations collection

January 2001 (has links)
Leung Yuet Kin. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2001. / Includes bibliographical references (p. 147-162). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.
4

Glycyrrhizic acid potentiates dsRNA-induced nitric oxide generation inalveolar macrophages

Ho, Wing-tak., 何永德. January 2004 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
5

Glycyrrhizic acid potentiates dsRNA-induced nitric oxide generation in alveolar macrophages

Ho, Wing-tak. January 2004 (has links)
Thesis (M. Med. Sc.)--University of Hong Kong, 2004. / Also available in print.
6

Active fraction of licorice inhibits proliferation of lung cancer cells A549 via inducing cell cycle arrest and apoptosis.

January 2012 (has links)
肺癌是導致男性死亡的最常見原因以及是排在乳腺癌和結腸癌之後的導致女性死亡的第三大原因。雖然肺癌如此嚴重,但是如今治疗肺癌仍然是一个挑战。現今對肺癌的治療主要集中在化學治療和靶點藥物治療,但是由於這些治療有著很大的副作用和低治愈率,尋找其他的醫學替代方法十分迫切。甘草是其中最常用的中藥,它常常用作食品工業中的甜味劑。以往的研究表明,甘草具有多種的生物活性。但是甘草提取物對於肺癌的治療卻是十分匱乏的。 / 本論文主要目的是評價甘草提取物以及其中的有效成份對非小型肺癌細胞株A549 的影響,以及其作用的機理。我們的數據表明,甘草的乙酸乙酯(EAL)成份比甘草的乙醇提取物有著比較強的抑制癌細胞的作用。另外,對甘草的五個單體進行的測試中發現lico-3 是最具有抑制肺癌作用的。利用高效液相色譜法對甘草活性成份分析表明,lico-3 是EAL中的其中一個單體。 / 乳酸脫氫酶滲漏(LDH)的檢測結果以及异硫氰酸荧光素-碘化丙啶(FITC-PI)雙染的結果表明,EAL 能夠引起肺癌細胞的凋亡現象而非壞死現象。實驗結果表明由EAL引起的A549細胞凋亡是跟Bcl-2家族及Caspase家族有關係,同時EAL還能夠抑制Akt途徑從而導致細胞的死亡。 / 致肺癌細胞死亡的原因進行進一步研究表明,EAL還能夠引起抑制細胞週期的運作,停留在G2/M 時期。這可能是由於EAL引發了p53與p21的上調作用從而抑制了細胞的生長與增殖。 / 實驗結果說明了EAL引起的肺癌細胞株A549的凋亡作用是跟多重細胞通路有關, 同時表明了EAL是具有抗擊肺癌作用的潛能,能夠作為治療肺癌的藥物。 / Lung cancer is the most common cause of cancer death in men and third in women followed by breast cancer and colon cancer, yet treatment of lung cancer remains a challenge. Current treatments including chemotherapy and targeted drug treatment come with side-effects and low successful rate. Alternative medicine for treatment of lung cancer is warranted. Glycyrrhiza uralensis (Gan-Cao), commonly called “licorice, is one of the most commonly used herbs in traditional Chinese medicine (TCM). It is also used as flavoring and sweetening agents in many of food products. Previous studies have indicated that licorice exhibits a variety of biological activities. However, anticancer effects of licorice extract on lung cancer remain unclear. / In this study, we evaluated effects of licorice extract and its chemical components on human lung cancer cell line A549, and studied its mode of action. Our results showed the ethyl acetate fraction of licorice (EAL) was more effective in inhibition of A549 cell growth followed by ETL (IC₅₀: 50μg/mL). Moreover, among the five compounds tested, lico-3 was more potent compound. The HPLC analysis of the active fraction indicated that lico-3 was one of the compounds distributed in the EA fraction. / The results of LDH assay and FITC-PI co-staining method suggested low concentration of EAL can trigger apoptosis but not necrosis. The experimental findings show that EAL induce apoptosis in A549 cell lines involved in Bcl-2 family and caspase cascade. Also, EAL can arrest the Akt survival pathway in A549. Furthermore, the results indicate that EAL triggered G2/M phase arrest. The studies suggest EAL can up-regulate p53 and p21 to promote cell cycle arrest resulting in inhibition of proliferation. / Experimental results indicate that EAL is involved in multiple signal pathways to induce lung cancer cell death. The result suggests EAL is a potential candidate for lung cancer therapy. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Detailed summary in vernacular field only. / Zhou, Yanling. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2012. / Includes bibliographical references (leaves 99-110). / Abstracts in Chinese. / Abstract --- p.III / 論文摘要 --- p.V / Acknowledgement --- p.VII / List of Contents --- p.VIII / List of Figures --- p.X / List of Tables --- p.XI / List of Abbreviations --- p.XII / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Lung cancer --- p.1 / Chapter 1.1.1 --- Overview --- p.1 / Chapter 1.1.2 --- Risk factors --- p.2 / Chapter 1.1.3 --- Types of lung cancer --- p.4 / Chapter 1.1.4 --- Stages and treatment of lung cancer --- p.5 / Chapter 1.1.5 --- Chemotherapy for lung cancer treatment --- p.8 / Chapter 1.2 --- Traditional Chinese Medicines --- p.11 / Chapter 1.2.1 --- Overview --- p.11 / Chapter 1.2.2 --- Licorice --- p.14 / Chapter 1.2.3 --- Chemical study of licorice --- p.16 / Chapter 1.2.4 --- Pharmacological activities of licorice --- p.16 / Chapter 1.3 --- Molecular mechanism of apoptosis --- p.21 / Chapter 1.3.1 --- Overview --- p.21 / Chapter 1.3.2 --- Bcl2 family --- p.21 / Chapter 1.3.3 --- Caspase pathway --- p.23 / Chapter 1.3.4 --- Akt pathway --- p.24 / Chapter 1.3.5 --- p53 protein --- p.26 / Chapter 1.3.6 --- Apoptosis and cancer --- p.27 / Chapter 1.4 --- Cell cycle --- p.29 / Chapter 1.4.1 --- Overview --- p.29 / Chapter 1.4.2 --- Cell cycle and p53 --- p.29 / Chapter 1.4.3 --- Cell cycle and cancer --- p.30 / Chapter 1.5 --- Aims of study --- p.32 / Chapter Chapter 2 --- Materials and Methods --- p.33 / Chapter 2.1 --- Cell culture and treatment --- p.33 / Chapter 2.1.1 --- Cell line --- p.33 / Chapter 2.1.2 --- Chemicals and reagents --- p.34 / Chapter 2.1.3 --- Preparation of solutions --- p.34 / Chapter 2.2 --- Preparation of Licorice sample --- p.35 / Chapter 2.3 --- HPLC analysis --- p.35 / Chapter 2.3.1 --- Chemical and materials --- p.35 / Chapter 2.3.2 --- Instrumentation --- p.36 / Chapter 2.3.3 --- Preparation of Standard solutions --- p.36 / Chapter 2.3.4 --- Preparation of samples --- p.37 / Chapter 2.3.5 --- HPLC conditions --- p.37 / Chapter 2.3.6 --- Method validation --- p.37 / Chapter 2.4 --- Cell viable assay --- p.38 / Chapter 2.4.1 --- Samples preparation --- p.39 / Chapter 2.4.2 --- Procedure --- p.39 / Chapter 2.5 --- LDH assay --- p.40 / Chapter 2.5.1 --- Reagent preparation --- p.40 / Chapter 2.5.2 --- Procedure --- p.41 / Chapter 2.6 --- Annexin V assay --- p.41 / Chapter 2.6.1 --- Reagent --- p.42 / Chapter 2.6.2 --- Procedure --- p.42 / Chapter 2.7 --- Cell cycle study --- p.43 / Chapter 2.7.1 --- Chemicals and reagent --- p.43 / Chapter 2.7.2 --- Procedure --- p.44 / Chapter 2.8 --- Caspase3/7 Assay --- p.44 / Chapter 2.8.1 --- Reagent preparation --- p.45 / Chapter 2.8.2 --- Procedure --- p.46 / Chapter 2.9 --- Western blotting --- p.46 / Chapter 2.9.1 --- Reagent and antibodies --- p.46 / Chapter 2.9.2 --- Procedure --- p.50 / Chapter 2.9.3 --- Determination of protein concentration --- p.51 / Chapter 2.10 --- Data analysis --- p.51 / Chapter Chapter 3 --- Results --- p.52 / Chapter 3.1 --- Chromatographic conditions and HPLC identity conformation --- p.52 / Chapter 3.1.1 --- Linearity, limits of detection and quantification --- p.56 / Chapter 3.1.2 --- Reproducibility --- p.56 / Chapter 3.1.3 --- Analysis of ethyl acetate of licorice (EAL) using the validated method --- p.56 / Chapter 3.2 --- Licorice induces apoptosis in nonsmall cell lung carcinoma --- p.61 / Chapter 3.2.1 --- Cell viability assay --- p.61 / Chapter 3.2.2 --- LDH leakage assay --- p.71 / Chapter 3.2.3 --- Annexin V and PI staining --- p.73 / Chapter 3.3 --- Protein expression in EALinduced apoptotic cells --- p.75 / Chapter 3.3.1 --- Bcl2 family --- p.75 / Chapter 3.3.2 --- Activation of caspases by EAL treatment --- p.77 / Chapter 3.4 --- EAL could block Akt survival pathway --- p.79 / Chapter 3.5 --- EAL induces cell cycle arrest in nonsmall cell lung carcinoma --- p.83 / Chapter Chapter 4 --- Discussion --- p.85 / Chapter 4.1 --- Chemical analysis of licorice --- p.85 / Chapter 4.2 --- Licorice induced apoptosis but not necrosis on lung cancer cell A549 --- p.86 / Chapter 4.2.1 --- Licorice exhibits specific cytotoxicity to different cancer cells in vitro --- p.86 / Chapter 4.2.2 --- EAL induces cell death via apoptosis but not necrosis --- p.87 / Chapter 4.3 --- Growth inhibition by EAL inducing apoptosis --- p.89 / Chapter 4.3.1 --- EAL induces apoptotic cell death through modification of Bcl2 family --- p.89 / Chapter 4.3.2 --- EAL activate the caspase proteins --- p.90 / Chapter 4.4 --- Growth inhibition by EAL inducing survival pathway arrest --- p.92 / Chapter 4.5 --- Growth inhibition by EAL inducing cellcycle arrest --- p.94 / Chapter 4.6 --- General discussion --- p.96 / Reference --- p.99
7

Cloning, expression and characterization of rat UDP-glucuronosyltransferase 1A8 (UGT1A8) and its induction by licorice extract and 18b-glycyrrhetinic acid.

January 2006 (has links)
Lee Kai Woo. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2006. / Includes bibliographical references (leaves 90-104). / Abstracts in English and Chinese. / Acknowledgements --- p.ii / Thesis Committee --- p.iii / Abstracts --- p.v / 論文槪要 --- p.vii / List of figures --- p.viii / List of abbreviations --- p.ix / Chapter Chapter one --- Introduction --- p.1 / Chapter 1.1 --- Drug metabolism and UGTs --- p.1 / Chapter 1.2 --- Natural substrates of UGTs --- p.4 / Chapter 1.3 --- Functions of UGT isoforms: roles of UGT polymorphisms --- p.6 / Chapter 1.4 --- Evolution of the UGT1 gene locus in vertebrates --- p.8 / Chapter 1.5 --- Multiple Variable First Exons: A Mechanism for Cell- and Tissue-Specific Gene regulation --- p.13 / Chapter 1.6 --- Evolutionary Origin of the Variable and Constant Genomic Organization --- p.14 / Chapter 1.7 --- Variable and Constant Genomic Organizations Exist in Mammalian UGTs --- p.20 / Chapter 1.8 --- The history of recombinant UGT expression --- p.20 / Chapter 1.9 --- UGT1A8 --- p.21 / Chapter 1.10 --- Licorice and its active component --- p.24 / Chapter 1.11 --- Enzyme induction in the liver --- p.25 / Chapter 1 12 --- Objectives --- p.28 / Chapter Chapter two --- Methods and Materials --- p.29 / Chapter 2.1 --- UGT1A8 induction studies --- p.30 / Chapter 2.1.1 --- Drug preparation --- p.30 / Chapter 2.1.2 --- Cell viability study with Neutral Red Assay Rat treatment --- p.30 / Chapter 2.1.3 --- Cell treatment --- p.31 / Chapter 2.1.4 --- Rat treatment --- p.31 / Chapter 2.1.5 --- RNA extraction from rat liver and cell culture --- p.31 / Chapter 2.1.6 --- Quantization of RNA --- p.32 / Chapter 2.1.7 --- Denaturing gel electrophoresis for RNA --- p.33 / Chapter 2.1.8 --- Northern hybridization --- p.33 / Chapter 2.1.9 --- Probe for Northern Blotting --- p.34 / Chapter 2.1.10 --- Agarose Gel analysis and Northern Blot analysis --- p.34 / Chapter 2.2 --- Recombinant expression of UGT1A8 in E.coli JM109 --- p.35 / Chapter 2.2.1 --- cDNA synthesis --- p.35 / Chapter 2.2.2 --- Polymerase chain reaction --- p.35 / Chapter 2.2.3 --- Agarose gel electrophoresis for DNA --- p.35 / Chapter 2.2.4 --- "Amplification of target gene, UGT1A8" --- p.36 / Chapter 2.2.5 --- Restriction enzyme digestion of plasmid and insert --- p.36 / Chapter 2.2.6 --- Ligation of plasmid and insert DNA --- p.37 / Chapter 2.2.7 --- Amplification of target plasmid --- p.37 / Chapter 2.2.8 --- Screening of target plasmid --- p.37 / Chapter 2.2.9 --- DNA sequencing --- p.38 / Chapter 2.2.10 --- Transformation of protein expression host --- p.38 / Chapter 2.2.11 --- Confirmation of transformation of protein expression host --- p.38 / Chapter 2.2.12 --- Protein expression --- p.39 / Chapter 2.2.13 --- Protein purification --- p.39 / Chapter 2.2.14 --- Sodium dodecyl sulfate polyacrylamide gel electrophoresis --- p.40 / Chapter 2.2.15 --- Confirmation of the protein --- p.40 / Chapter 2.3 --- Characterization of recombinant UGT1A8 --- p.41 / Chapter 2.3.1 --- UGT assay --- p.41 / Chapter 2.4 --- Routine experiment methods --- p.41 / Chapter 2.4.1 --- Determination of protein --- p.41 / Chapter 2.4.2 --- Nucleic acid purification --- p.42 / Chapter 2.4.3 --- Preparation of chemically competent bacterial cells --- p.42 / Chapter 2.4.4 --- Colony PCR --- p.43 / Chapter 2.4.5 --- Plasmid rescue by alkaline lysis --- p.44 / Chapter 2.4.6 --- Charging of His-tagged column --- p.44 / Chapter 2.4.7 --- Washing of His-tagged column --- p.45 / Chapter Chapter three --- Results --- p.46 / Chapter 3.1 --- UGT1A8 Expression in clone9 and H4IIE after treatment with licorice and 18 β glycyrrhentinic acid --- p.46 / Chapter 3.2 --- UGT1A8 induction in wistar and j/j rats after treatment --- p.63 / Chapter 3.3 --- Construction of pRset-UGT 1A8 Vector --- p.70 / Chapter 3.4 --- Purification of recombinant UGT1A8 --- p.75 / Chapter 3.5 --- Screening of substrate of the purified enzyme --- p.77 / Chapter Chapter four --- Discussion --- p.78 / Chapter 4.1 --- Effects of licorice and 18βglycyrrhetinic acid in the induction of UGT1A8 in different cell lines --- p.78 / Chapter 4.2 --- Comparison of wistar and j/j rats in the induction of UGT1A8 --- p.79 / Chapter 4.3 --- Comparison of licorice and 18(3 glycyrrhetinic acid in the induction of UGT1A8 in rats --- p.81 / Chapter 4.4 --- Comparison of in vivo and in vitro of drug treatment --- p.81 / Chapter 4.5 --- Expression of UGT1A7 after drug treatment in vitro --- p.82 / Chapter 4.6 --- Protein expression and purification --- p.83 / Chapter 4.7 --- Substrates of UGT1A8 --- p.83 / Chapter Chapter Five --- Conclusions --- p.86 / References --- p.90 / Appendix --- p.105
8

Exploration of the anticancer mechanisms of novel chemotherapeutic adjuvants involving autophagy and immune system reprogramming in the treatment of pancreatic cancer

Zhang, Zhu 11 June 2020 (has links)
Pancreatic cancer is known to be one of the most life-threatening cancers characterized by aggressive local invasion and distant metastasis. The high basal level of autophagy in pancreatic cancer may be responsible for the low chemotherapeutic drug response rate and poor disease prognosis. However, the clinical application of autophagy inhibitors was unsatisfactory due to their toxicity and minimal single-agent anticancer efficacy. Hence, oncologists begin to consider the tumor microenvironment when exploring new drug targets. In the present study, the anti-tumorigenic mechanisms of two major phytochemicals derived from Chinese medicinal herbs had been investigated against pancreatic cancer development. Calycosin is a bioactive isoflavonoid of the medicinal plant Astragalus membranaceus. Our results have shown that calycosin inhibited the growth of various pancreatic cancer cells both in vitro and in vivo by inducing cell cycle arrest and apoptosis. Alternatively, calycosin also facilitated MIA PaCa-2 pancreatic cancer cell migration in vitro and increased the expression of epithelial-mesenchymal transition (EMT) biomarkers in vivo. Further mechanistic study suggests that induction of the Raf/MEK/ERK pathway and facilitated polarization of M2 tumor-associated macrophage in the tumor microenvironment both contribute to the pro-metastatic potential of calycosin in pancreatic cancer. These events appear to be associated with calycosin-evoked activation of TGF-β signaling, which may explain the paradoxical drug actions due to the dual roles of TGF-β as both tumor suppressor and tumor promoter in pancreatic cancer development under different conditions. Isoliquiritigenin (ISL) is a chalcone obtained from the medicinal plant Glycyrrhiza glabra, which can be a precursor for chemical conversion to form calycosin. Results have shown that ISL decreased the growth and EMT of pancreatic cancer cells in vitro, probably due to modulation of autophagy. ISL-induced inhibition of autophagy subsequently promoted reactive oxygen species (ROS) production, leading to induction of apoptosis in pancreatic cancer cells. Such phenomenon also contributed to the synergistic growth-inhibitory effect in combined treatment with the orthodox chemotherapeutic drug 5-fluorouracil. In addition, ISL-induced tumor growth inhibition in vivo was further demonstrated in a tumor xenograft mice model of pancreatic cancer. ISL promoted apoptosis and inhibited autophagy in the tumor tissues. Study on immune cells indicates that ISL could reduce the number of myeloid-derived suppressor cells (MDSCs) both in tumor tissue and in peripheral blood, while CD4+ and CD8+ T cells were increased correspondingly. In vitro test has revealed that ISL inhibited the polarization of M2 macrophage along with its inhibition of autophagy in M2 macrophage. These immunomodulating effects of ISL had reversed the pro-invasive role of M2 macrophage in pancreatic cancer.In conclusion, calycosin acts as a "double-edged sword" on the growth and metastasis of pancreatic cancer, which may be related to the dual roles of TGF-β and its influence on the tumor microenvironment. Alternatively, ISL consistently inhibited the growth and metastatic drive of pancreatic cancer through regulation of autophagy and reprogramming of the immune system. The differential modes of action of these compounds have provided new insights in the development of effective pancreatic cancer treatment adjuvants.
9

An investigation of compounds isolated from Glycyrrhiza Glabra (Liquorice root)

Raubenheimer, Carike 10 1900 (has links)
Introduction: Dark spots appearing on the skin caused by hyperpigmentation results from the action of tyrosinase, an enzyme whose activity leads to the production of the skin pigment melanin. Extracts of the plant Glycyrrhiza glabra, also known as liquorice, are commonly used to treat a range of conditions including skin hyperpigmentation. This study aimed at isolating and identifying compounds in extracts from South African liquorice root and assaying these compounds as to their antioxidant activity, their ability to inhibit the tyrosinase enzyme and their level of cytotoxicity. Methods: The ability of plant extracts to scavenge free radicals was tested using the 2,2-diphenyl-1-picrylhydrazyl (DPPH), [2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonicacid)] (ABTS) and the ferric ion reducing power (FRAP) tests. The polyphenolic content of extract fractions was determined and extract compounds were identified using UHPLC-QToF-20 MS. In vitro anti-tyrosinase activity was also investigated as well as cytotoxicity in HepG2 liver and SK-MEL-1 melanoma cells using the MTT cell viability assay. Results: Of the four fractions prepared from the 70% methanolic extract of liquorice root, fraction 3 (F3) showed increased polyphenolic content and antioxidant properties with IC50 of 56.1 ± 6.32, 39.14 ± 1.1 and 66.34 ± 1.4 μg/ml against DPPH, ABTS and FRAP, respectively. The anti-tyrosinase activity of this fraction showed an IC50 of 358.54 μg/ml compared to Kojic acid (0.75 mM) used as the control. In addition, this fraction showed reduced liver toxicity as a higher percentage cell viability was noted in the HepG2 cells compared to the SK-MEL-1 skin melanoma cells. However, both cell types showed higher percentage viability compared to acetaminophen that was used as cytotoxic control. The LC-MS analysis revealed the presence of a wide variety of compounds including 4-azido-3-benzyl-coumarin, ferulic acid, glycyrrhizin, quercitrin, cirsilineol, gentioflavine and 4'',6,7-trihydroxyisoflavone. The literature indicates the use of these compounds regarding antioxidant and anti-tyrosinase activity. Significantly, cularidine was identified in this study, a compound not previously reported in studies involving liquorice root. Conclusion: The results from this study concur with previous reports as to the anti-tyrosinase and antioxidant activities associated with liquorice roots, activities perhaps due to the relatively high polyphenolic content in extracts from South African liquorice root. / Life and Consumer Sciences / M. Sc. (Life Sciences)

Page generated in 0.0631 seconds